Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Annovis Bio Inc (NYSE: ANVS) closed at $4.92 up 2.07% from its previous closing price of $4.82. In other words, the price has increased by $2.07 from its previous closing price. On the day, 2.92 million shares were traded. ANVS stock price reached its highest trading level at $5.25 during the session, while it also had its lowest trading level at $4.57.
Ratios:
For a deeper understanding of Annovis Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.60 and its Current Ratio is at 4.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 25, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $25. On December 29, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $36.Canaccord Genuity initiated its Buy rating on December 29, 2023, with a $36 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 24 ’25 when Hoffman Michael B bought 39,200 shares for $4.08 per share. The transaction valued at 159,886 led to the insider holds 2,519,739 shares of the business.
Hoffman Michael B bought 20,000 shares of ANVS for $69,900 on Nov 21 ’25. The Director now owns 2,490,539 shares after completing the transaction at $3.50 per share. On Nov 14 ’25, another insider, Hoffman Michael B, who serves as the Director of the company, bought 15,000 shares for $2.11 each. As a result, the insider paid 31,650 and bolstered with 2,470,539 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANVS now has a Market Capitalization of 130394208 and an Enterprise Value of 115107816.
Stock Price History:
The Beta on a monthly basis for ANVS is 1.36, which has changed by -0.266766 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, ANVS has reached a high of $7.39, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 106.03%, while the 200-Day Moving Average is calculated to be 121.24%.
Shares Statistics:
For the past three months, ANVS has traded an average of 1.59M shares per day and 6932230 over the past ten days. A total of 26.50M shares are outstanding, with a floating share count of 22.40M. Insiders hold about 15.28% of the company’s shares, while institutions hold 11.40% stake in the company. Shares short for ANVS as of 1763078400 were 1314516 with a Short Ratio of 0.82, compared to 1760486400 on 1298376. Therefore, it implies a Short% of Shares Outstanding of 1314516 and a Short% of Float of 5.54.
